Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
Accelerate Diagnostics, Inc. (AXDX)
Last accelerate diagnostics, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axdx.com/investors
Company Research
Source: GlobeNewswire
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of 2.50% convertible senior notes due 2023 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). An entity affiliated with one of Accelerate Diagnostics’s directors has agreed to purchase an aggregate of $30 million of the notes. Accelerate Diagnostics also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on March 27, 2018, subject to customary closing conditions, and is expected to result in approximately $145.6 million in net proceeds to Accelerate Diagnostics (or $167.4 million if the initial purchasers exercise their option to
Show less
Read more
Impact Snapshot
Event Time:
AXDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXDX alerts
High impacting Accelerate Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
AXDX
News
- Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsPR Newswire
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- North America Molecular Diagnostics Analysis Report 2024: Market to Reach $7.23 Billion by 2030, Driven by Early Disease Detection, External Funding, and Strategic Partnerships [Yahoo! Finance]Yahoo! Finance
- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
AXDX
Earnings
- 3/28/24 - Miss
AXDX
Sec Filings
- 3/6/24 - Form 4
- 3/6/24 - Form 4
- 3/6/24 - Form 4
- AXDX's page on the SEC website